Efficacy and Safety of Relacorilant + Nab-paclitaxel in Patients Aged ≥65 Years With Platinum-resistant Ovarian Cancer (PROC) in the Phase 3 ROSELLA Study (GOG-3073, ENGOT-OV72, APGOT-Ov10)
Presented: European Society for Medical Oncology Gynaecological Cancers Annual Congress, 18 June 2026, Copenhagen, DK
Presenter: Domenica Lorusso, MD, PhD
Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.